AZGP1 and Ureteral obstruction: Here, we tested new opportunities for the therapeutic potential of AZGP1 using murine unilateral ureteral obstruction (UUO) as a fibrotic kidney disease model and evaluated potential implications of AZGP1 in renal lipid metabolism.